Entity Details

Primary name CRBB2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP43320
EntryNameCRBB2_HUMAN
FullNameBeta-crystallin B2
TaxID9606
Evidenceevidence at protein level
Length205
SequenceStatuscomplete
DateCreated1995-11-01
DateModified2021-06-02

Ontological Relatives

GenesCRYBB2

GO terms

Show/Hide Table
GOName
GO:0002088 lens development in camera-type eye
GO:0005198 structural molecule activity
GO:0005212 structural constituent of eye lens
GO:0007601 visual perception
GO:0042802 identical protein binding
GO:0050896 response to stimulus

Subcellular Location

Show/Hide Table

Domains

Show/Hide Table
DomainNameCategoryType
IPR001064 Beta/gamma crystallinDomainDomain
IPR011024 Gamma-crystallin-likeFamilyHomologous superfamily
IPR033058 Beta-crystallin B2FamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
601547 OMIMCataract 3, multiple types (CTRCT3)An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT3 includes congenital cerulean and sutural cataract with punctate and cerulean opacities, among others. Cerulean cataract is characterized by peripheral bluish and white opacifications organized in concentric layers with occasional central lesions arranged radially. The opacities are observed in the superficial layers of the fetal nucleus as well as the adult nucleus of the lens. Involvement is usually bilateral. Visual acuity is only mildly reduced in childhood. In adulthood, the opacifications may progress, making lens extraction necessary. Histologically the lesions are described as fusiform cavities between lens fibers which contain a deeply staining granular material. Although the lesions may take on various colors, a dull blue is the most common appearance and is responsible for the designation cerulean cataract. Sutural cataract with punctate and cerulean opacities is characterized by white opacification around the anterior and posterior Y sutures, and grayish and bluish, spindle shaped, oval punctate and cerulean opacities of various sizes arranged in lamellar form. The spots are more concentrated towards the peripheral layers and do not delineate the embryonal or fetal nucleus. Phenotypic variation with respect to the size and density of the sutural opacities as well as the number and position of punctate and cerulean spots is observed among affected subjects. The disease is caused by variants affecting the gene represented in this entry.

Interactions

11 interactions